Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression

Journal Title: Psychiatria Polska - Year 2012, Vol 46, Issue 2

Abstract

Clinical practice and data from literature indicate that up to 30% of the patients suffering from depression meet criteria for treatment-resistant depression. In the past decade, interest in the use of NMDA receptor modulators in the treatment of treatment-resistant depression is increasing. The use of ketamine – an noncompetitive antagonist of the NMDA receptors, allows some patients suffering from treatment resistant depression to achieve rapid and significant improvement. The authors reviewed results of clinical studies, series of cases and case reports on the use of ketamine. Most of the patient suffered from the treatment-resistant major depression. Neurobiological basis of the glutaminergic pathways and the postulated role of glutamate in mood modulation have been described, as well as possible adverse events associated with ketamine infusion. Concerns relate to the optimal dosage, frequency of administration, long-term safety and efficacy of the therapy. Interesting results of the published articles encourage further studies on therapeutic use of NMDA receptor modulators in the treatment of treatment-resistant depression.

Authors and Affiliations

Paweł Gosek, Magdalena Chojnacka, Przemysław Bieńkowski, Łukasz Święcicki

Keywords

Related Articles

Duże zwierzęta jako potencjalne modele zaburzeń psychicznych i zachowania człowieka

Streszczenie Wiele modeli zwierzęcych różnych gatunków zostało opracowanych dla zaburzeń psychicznych i behawioralnych. Ten przegląd prezentuje duże zwierzęta (pies, owca, świnia, koń) jako potencjalne modele tych zaburz...

International Classification of Mental Health Care (ICMHC) – description and application

Over the last decades the interest in evaluating mental health care has greatly increased, in particular with regard to the possibilities to evaluate the health care process. It is connected with three processes: decentr...

Delusion of sex change and body dysmorphic disorder in clinical picture of paranoid schizophrenia – case reports

Summary Aim. The aim of the paper was to present the basic data about delusions of sex change and body dysmorphic disorder and describe two cases of patients with these symptoms and paranoid schizophrenia. Method. Anal...

Depresja u chorych z padaczką

Depresja jest jednym z najczęstszych zaburzeń psychicznych towarzyszących padaczce. Za przyczynę występowania depresji u pacjentów z padaczką uważa się: zmiany neurochemiczne i neurofizjologiczne, zachodzące w strukturac...

Neuroimmunologia choroby afektywnej dwubiegunowej

Previous neuroimmunological studies focused mostly on depression, regardless of its diagnostic category. In this paper, the studies on the immunological system in patients with bipolar affective illness, including manic...

Download PDF file
  • EP ID EP103524
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

Paweł Gosek, Magdalena Chojnacka, Przemysław Bieńkowski, Łukasz Święcicki (2012). Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression. Psychiatria Polska, 46(2), 283-294. https://europub.co.uk/articles/-A-103524